Bay Street News, 2024

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabine Results from this Phase 2 trial […]

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical […]

GLYFADA, Greece, Oct. 02, 2024 (GLOBE NEWSWIRE) — Globus Maritime Limited (the “Company” or “Globus”) (NASDAQ: GLBS), a dry bulk […]

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that it has entered into an agreement […]

CHANTILLY, Va., Oct. 02, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was awarded a […]

PLANO, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical […]

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) — MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that it […]

BATON ROUGE, La., Oct. 02, 2024 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (Nasdaq: BFST), the parent company of b1BANK, […]

TORONTO and OTTAWA, Oct. 02, 2024 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: […]

CALGARY, Alberta, Oct. 02, 2024 (GLOBE NEWSWIRE) — Precision Drilling Corporation (Precision) intends to release its 2024 third quarter results […]